comparemela.com
  1. Home
  2. Live Updates
  3. Christian Dinneen - Breaking News

Latest Breaking News On - Christian dinneen - Page 1 : comparemela.com

GlycoMimetics, Inc (NASDAQ:GLYC) Q4 2023 Earnings Call Transcript

Operator: Good morning, and thank you for joining the GlycoMimetics Q4 and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.

United statesTara bancroftChristian dinneenBruce johnsonBrian hahnHarout semerjianNaureen quibriaChildren oncology group phaseCompany counsel at glycomimeticsGlycomimetics incPediatric early phase clinical trial networkDana farber cancer instituteAmerican cancer societyNational cancer instituteAlliance for clinical trials in oncologyAmerican society of hematology research collaborative

GlycoMimetics, Inc (NASDAQ:GLYC) Q3 2023 Earnings Call Transcript

Operator: Good morning, and thank you for joining the GlycoMimetics Q3 2023 Earnings Call. At this time, all participants are in a listen-only mode.

San diegoUnited statesDana farber cancer instituteDebora peraltaHarout semerjianGaetano bonifacioJohn horanChristian dinneenBrian hahnCompany counsel at glycomimeticsWashington universityAmerican society of hematologyMd anderson cancer centerAlliance for clinical trials in oncologyNational cancer instituteGlobal medical affairs

GlycoMimetics, Inc (NASDAQ:GLYC) Q2 2023 Earnings Call Transcript

Operator: Good morning, and thank you for joining the GlycoMimetics, Q2 2023 Earnings Call. At this time all participants are in listen-only mode.

United statesDana farber cancer instituteBrian hahnChristian dinneenHarout semerjianJohn moranJohn horanGlycomimetics incData monitoring committeeCompany counsel at glycomimeticsNational cancer instituteCall transcript augustChristian dinneen longCompany counselChief executive officer brian hahnChief financial officer

GlycoMimetics, Inc (NASDAQ:GLYC) Q4 2022 Earnings Call Transcript

Operator: Good morning. And thank you for joining the GlycoMimetics Fourth Quarter and Full Year 2022 Earnings Call. At this time, all participants are in a listen only mode.

Christian dinneenHarout semerjianBrian hahnChinmaya rathCompany council at glycomimeticsHealth photoGlycomimetics incCall transcript marchGlycomimetics fourth quarterFull yearChristian dinneen longCompany councilChief executive officerChief financial officerEdwin rockChief medical

GlycoMimetics, Inc (GLYC) CEO Harout Semerjian on Q2 2022 Results - Earnings Call Transcript

GlycoMimetics, Inc. (NASDAQ:NASDAQ:GLYC) Q2 2022 Earnings Conference Call August 03, 2022 08:30 AM ET Company Participants Christian Dinneen-Long - Company Counsel Harout Semerjian - Chief.

New yorkUnited statesChristian dinneenBruce johnsonHarout semerjianSteve berseyBrian hahnRed whiteCompany participantsNational cancer instituteGlycomimetics incCompany counselNational comprehensive cancer networkConference call augustChristian dinneen longInvestor relations

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.